Transcription of High and Moderate- Intensity Statin Table
1 high and moderate - Intensity Statin Table
Example: bankruptcy
High and Moderate- Intensity Statin Table
high and moderate - Intensity Statin Table
Rosuvastatin 5—10 mg Simvastatin 20—40 mg Ezetimibe-simvastatin 20-40 mg Niacin-simvastatin 20-40 mg . Author: Emily Endres Created Date: 4/24/2019 9:28:18 AM ...
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
Potentially Harmful Drugs in the Elderly: Beers List
www.pharmacyquality.comstarting or changing dose. Of special concern in patients with dementia, cognitive impairment, delirium or high risk of delirium, history of falls or fractures, lower urinary symptoms, or BPH (avoid in men). Tertiary amines (amitriptyline, clomipramine, doxepin, imipramine, trimipramine) of special concern in patients with syncope due to risk of
Related documents
Statin Prescribing
www.gloshospitals.nhs.uktolerated doses of statin monotherapy (avoid simvastatin 80mg) has been demonstrated. • When decision has been made to treat with ezetimibe coadministered with a statin, ezetimibe should be prescribed on the basis of lowest acquisition cost …
ACC/AHA lipid guidelines: Personalized care to prevent ...
www.ccjm.org100 mg/dL with maximal tolerated statin therapy, ezetimibe can be added (class IIb rec-ommendation, ie, weak recommendation, but benefi t exceeds risk). If the patient has a risk factor for athero-sclerotic cardiovascular disease and his or her LDL-C level remains higher than 100 mg/dL even after adding ezetimibe to the statin, a
V DIRETRIZ BRASILEIRA DE DISLIPIDEMIAS E PREVENÇÃO DA ...
publicacoes.cardiol.brca é de 10/10 mg/dia até 10/80 mg/dia. A dose inicial usual recomendada de VYTORIN é de de 10/20 mg/dia, sempre em dose única, à noite, com ou sem alimentos. Quando a redução de LDL-C desejada for superior a 55%, pode-se iniciar com 10/40 mg/dia. Administração concomitante com fibratos: 10/10 mg/dia ou 10/20 mg
STANDARD OPTION - Caremark
www.caremark.comSTANDARD OPTION Effective January 1, 2022, selected drugs will no longer be covered under Standard Option. These non-covered drugs have available covered options in